Literature DB >> 9706117

Intensive treatment of type 1 diabetes.

I B Hirsch1.   

Abstract

There have been amazing advances for the treatment of type 1 diabetes. As clinicians proceed into the twenty-first century, it is appropriate to reflect both about accomplishments and about the prospects of improved therapeutic options. Regarding the former, perhaps no advance can be compared to the discovery of insulin. Since then, the improvements in therapy have appeared to be too slow for physicians, patients, and their families. In actuality, over the past 20 years, the pace for the development of new tools for the treatment of this once fatal disease has been remarkable. The treatment of type 1 diabetes has evolved with advances in the treatment of microvascular, neuropathic, and macrovascular complications. The future is even more promising, with the possibility of even preventing the disease before the development of hyperglycemia. The challenge for the present is teaching all individuals involved with the management of patients with type 1 diabetes to manage the condition as effectively as possible.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9706117     DOI: 10.1016/s0025-7125(05)70020-1

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  6 in total

Review 1.  Evolving approaches to intensive insulin therapy in type 1 diabetes: multiple daily injections, insulin pumps and new methods of monitoring.

Authors:  Elizabeth Stephens; Matthew Riddle
Journal:  Rev Endocr Metab Disord       Date:  2003-12       Impact factor: 6.514

Review 2.  New aspects of insulin therapy in type 1 and type 2 diabetes.

Authors:  D G Dills
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

Review 3.  Clinical pharmacokinetics and pharmacodynamics of insulin glulisine.

Authors:  Reinhard H A Becker; Annke D Frick
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

Review 4.  Intensive diabetes management in pediatric patients.

Authors:  B Buckingham; B Bluck; D M Wilson
Journal:  Curr Diab Rep       Date:  2001-08       Impact factor: 4.810

5.  Comparison of the efficacy and safety of insulin glargine and insulin detemir with NPH insulin in children and adolescents with type 1 diabetes mellitus receiving intensive insulin therapy.

Authors:  Bumin Nuri Dündar; Nihal Dündar; Erdal Eren
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-05-04

Review 6.  Insulin glargine in the treatment of type 1 and type 2 diabetes.

Authors:  Anthony H Barnett
Journal:  Vasc Health Risk Manag       Date:  2006
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.